NEUROTROPHINCELL PTY LTD has a total of 20 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are OSIRIS THERAPEUTICS INC, NAUGHTON GAIL K and THEREGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | New Zealand | 2 | |
#7 | China | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Skinner Stephen John Martin | 17 |
#2 | Elliott Robert Bartlett | 13 |
#3 | Tan Paul Lip Jin | 6 |
#4 | Thanos Christopher | 6 |
#5 | Williams Christopher Edward | 5 |
#6 | Emerich Dwaine | 4 |
#7 | Orellana Livia Del Carmen Esco | 4 |
#8 | Borlongan Cesar Venturina | 3 |
#9 | Vasconcellos Alfred | 3 |
#10 | Martin Skinner Stephen John | 2 |
Publication | Filing date | Title |
---|---|---|
US2010310627A1 | Xenotransplant for Stroke Therapy | |
WO2010030199A1 | Stem cell culture | |
US2009047325A1 | Xenotransplant for cns therapy | |
US2009075375A1 | Choroid plexus preparation and uses thereof | |
US2008119909A1 | Cell implantation to prevent and/or treat hearing loss | |
NZ540597A | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells | |
NZ536009A | Choroid plexus preparation and uses thereof | |
EP1176970A2 | Xenotransplant for cns therapy |